Delayed Reduction in Left Ventricular Function following Treatment of Non-Hodgkin’s Lymphoma with Chemotherapy and Rituximab, Unrelated to Acute Infusion Reaction

Publisher： Karger

E-ISSN： 1421-9751|105|3|184-187

ISSN： 0008-6312

Source： Cardiology, Vol.105, Iss.3, 2006-04, pp. : 184-187

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antibody Therapy with Rituximab for Patients with Low-Grade Non-Hodgkin’s Lymphoma

By  

Oncology Research and Treatment, Vol. 22, Iss. 3, 1999-07 ,pp. : 184-190

Karger

Access to resources Recommend Favorite

Rituximab in Combination with Interferon-Alpha in Relapsed and Refractory Diffuse Large B-Cell Non-Hodgkin’s Lymphoma

By  

Acta Haematologica, Vol. 106, Iss. 3, 2001-11 ,pp. : 141-142

Karger

Access to resources Recommend Favorite

Acute Toxicity of Mitoxantrone, Chlorambucil and Prednisolone (MCP) versus MCP plus Rituximab in Low-Grade Non-Hodgkin’s Lymphoma – Interim Results of a Phase III Trial

By  

Oncology Research and Treatment, Vol. 23, Iss. 2, 2000-05 ,pp. : 164-166

Karger

Access to resources Recommend Favorite

Primary Non-Hodgkin’s Lymphoma of Urinary Bladder

By  

Urologia Internationalis, Vol. 72, Iss. 1, 2004-01 ,pp. : 82-84

Karger

Access to resources Recommend Favorite

Primary Non-Hodgkin’s Lymphoma of the Rectum

By  

Oncology Research and Treatment, Vol. 30, Iss. 7, 2007-06 ,pp. : 385-387

Karger

Access to resources Recommend Favorite